Advertisement
Advertisement

ATNM

ATNM logo

Actinium Pharmaceuticals, Inc

1.01
USD
Sponsored
-0.01
-0.98%
Jun 24, 15:56 UTC -4
Closed
exchange

After-Market

1.04

+0.03
+2.87%

ATNM Earnings Reports

Positive Surprise Ratio

ATNM beat 24 of 42 last estimates.

57%

Next Report

Date of Next Report
Aug 06, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.22
Implied change from Q1 26 (Revenue/ EPS)
--
/
+22.22%
Implied change from Q2 25 (Revenue/ EPS)
--
/
--

Actinium Pharmaceuticals, Inc earnings per share and revenue

On May 08, 2026, ATNM reported earnings of -0.18 USD per share (EPS) for Q1 26, beating the estimate of -0.23 USD, resulting in a 24.91% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.29% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.22 USD, with revenue projected to reach -- USD, implying an increase of 22.22% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q1 2026, Actinium Pharmaceuticals, Inc reported EPS of -$0.18, beating estimates by 24.91%, and revenue of $0.00, 0% as expectations.
The stock price moved up 2.29%, changed from $1.31 before the earnings release to $1.34 the day after.
The next earning report is scheduled for Aug 06, 2026.
Based on 3 analysts, Actinium Pharmaceuticals, Inc is expected to report EPS of -$0.22 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement